[HTML][HTML] Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains …

SE Jossi, M Arcuri, A Alshayea, RR Persaud… - Frontiers in …, 2023 - frontiersin.org
Introduction Vaccination with Vi capsular polysaccharide (Vi-PS) or protein-Vi typhoid
conjugate vaccine (TCV) can protect adults against Salmonella Typhi infections. TCVs offer …

Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the …

S Jossi, M Arcuri, A Alshayea, R Persaud… - Frontiers in …, 2023 - europepmc.org
Methods and results Here, we immunized wild-type (WT) mice and mice deficient in IgG or
IgM with Vi-PS or TCVs (Vi conjugated to tetanus toxoid or CRM197) for up to seven months …

Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the …

S Jossi, M Arcuri, A Alshayea… - Frontiers in …, 2023 - research.birmingham.ac.uk
Abstract Introduction: Vaccination with Vi capsular polysaccharide (Vi-PS) or protein-Vi
typhoid conjugate vaccine (TCV) can protect adults against Salmonella Typhi infections …

Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the …

SE Jossi, M Arcuri, A Alshayea, RR Persaud… - bioRxiv, 2023 - biorxiv.org
Vaccination with Vi capsular polysaccharide (Vi-PS) or protein-Vi typhoid conjugate vaccine
(TCV) can protect adults against Salmonella Typhi infections. TCVs offer better protection …

Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the …

SE Jossi, M Arcuri, A Alshayea, RR Persaud… - Frontiers in …, 2023 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Introduction</jats: title>< jats: p> Vaccination with Vi capsular
polysaccharide (Vi-PS) or protein-Vi typhoid conjugate vaccine (TCV) can protect adults …

[PDF][PDF] Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains …

LH Bäumler, KM Toellner, CA MacLennan, R Ian… - researchgate.net
2. GSK Vaccines Institute for Global Health srl., Siena, Italy 3. Department of Medical
Microbiology and Immunology, School of Medicine, University of California, Davis, CA …

[引用][C] Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains …

SE Jossi, M Arcuri, A Alshayea… - Frontiers in …, 2023 - espace.library.uq.edu.au
Introduction: Vaccination with Vi capsular polysaccharide (Vi-PS) or protein-Vi typhoid
conjugate vaccine (TCV) can protect adults against Salmonella Typhi infections. TCVs offer …

[HTML][HTML] Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains …

SE Jossi, M Arcuri, A Alshayea, RR Persaud… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Methods and results Here, we immunized wild-type (WT) mice and mice deficient in IgG or
IgM with Vi-PS or TCVs (Vi conjugated to tetanus toxoid or CRM197) for up to seven months …

Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the …

SE Jossi, M Arcuri, A Alshayea… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Vaccination with Vi capsular polysaccharide (Vi-PS) or protein-Vi typhoid
conjugate vaccine (TCV) can protect adults against Salmonella Typhi infections. TCVs offer …

Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the …

SE Jossi, M Arcuri, A Alshayea, RR Persaud… - Frontiers in …, 2023 - europepmc.org
Methods and results Here, we immunized wild-type (WT) mice and mice deficient in IgG or
IgM with Vi-PS or TCVs (Vi conjugated to tetanus toxoid or CRM197) for up to seven months …